LDS/Medical Tests/G-protein gated Inwardly Rectifying K+ channel 1 (GIRK1) Genotyping

G-protein gated Inwardly Rectifying K+ channel 1 (GIRK1) Genotyping

G-protein gated Inwardly Rectifying K+ channel 1 (GIRK1), encoded by the KCNJ3 gene, is part of the inward rectifier potassium channel family (TC 1.A.2.1). The gene is located on chromosome 2 (2q24.1). GIRK1 channels are critical for neuronal excitability, cardiac rhythm regulation, and neurotransmitter signaling. They form heterotetrameric channels with other GIRK subunits (GIRK2, GIRK3, GIRK4) and are activated by G-protein coupled receptors (GPCRs).

A key variant, GRIK1 rs2832407, involves a C>A non-coding change. The C allele, predominant in European Americans, is associated with alcohol dependence susceptibility. Studies indicate that individuals with the homozygous C/C genotype show an improved response to topiramate therapy for alcohol dependence compared to C/A and A/A genotypes. The frequencies of the GRIK1 rs2832407 C allele are 63%, 40-50% and 11% in Caucasians, Asians and Africans respectively.

Topiramate is an FDA-approved anticonvulsant and migraine prophylactic. Off-label applications include treatment for essential tremors, smoking cessation, and alcohol dependence. Genetic screening for GRIK1 polymorphisms may help personalize topiramate therapy for individuals with alcohol addiction.

  • Identification of genetic predisposition to alcohol dependence
  • Personalized medicine approach for topiramate efficacy in alcohol use disorder
  • Potential implications in cardiac arrhythmias and neurological disorders
Genotype Clinical Relevance
C/C (Homozygous) Associated with better response to topiramate therapy for alcohol dependence
C/A (Heterozygous) Intermediate response to topiramate therapy
A/A (Homozygous) Lower likelihood of response to topiramate therapy

 

rs2832407 C/C (Normal Genotype)

Polymerase Chain Reaction (PCR), Sanger Sequencing, Next-Generation Sequencing (NGS), Multiplex Ligation-Dependent Probe Amplification (MLPA),

Whole Blood (EDTA).

Stability

  • Ambient: 3-5 days
  • Refrigerated: 7-14 days
  • Frozen: 30 days

For Breast Tissue Analysis:

  • Formalin-Fixed Paraffin-Embedded (FFPE) Tissue
BRCA1/2 Gene Mutation Analysis (for breast cancer predisposition), High-Sensitivity C-Reactive Protein (hs-CRP) (for inflammation assessment), Cardiac Troponins (myocardial injury), CK-MB (cardiac ischemia), KCNJ5 (GIRK4) Gene Mutation Analysis (linked to familial hyperaldosteronism).
3-7 days.
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login